StonvexLoading…
StonvexCore line items from STLD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $18.18B | $17.54B | $18.80B | $22.26B |
Operating Income | $1.48B | $1.94B | $3.15B | $5.09B |
Net Income | $1.19B | $1.54B | $2.45B | $3.86B |
EPS (Diluted) | $7.99 | $9.84 | $14.64 | $20.92 |
Total Assets | $16.42B | $14.94B | $14.91B | $14.16B |
Total Liabilities | $7.49B | $5.99B | $6.07B | $6.06B |
Cash & Equivalents | $769.88M | $589.46M | $1.40B | $1.63B |
Free Cash Flow OCF − CapEx | $501.51M | $-23.50M | $1.86B | $3.55B |
Shares Outstanding | 144.94M | 151.12M | 160.02M | 172.94M |